Your browser doesn't support javascript.
loading
Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
Golay, Josée; Choblet, Sylvie; Iwaszkiewicz, Justyna; Cérutti, Pierre; Ozil, Annick; Loisel, Séverine; Pugnière, Martine; Ubiali, Greta; Zoete, Vincent; Michielin, Olivier; Berthou, Christian; Kadouche, Jean; Mach, Jean-Pierre; Duonor-Cérutti, Martine.
Affiliation
  • Golay J; Centro di Terapia Cellulare "G. Lanzani," Divisione di Ematologia, Azienda Ospedaliera Papa Giovanni XXIII, 24122 Bergamo, Italy; Jean-Pierre.Mach@unil.ch jgolay@asst-pg23.it.
  • Choblet S; Centre National de la Recherche Scientifique UPS3044 "Baculovirus et Thérapie," F-30380 Saint-Christol-Lèz Alès, France;
  • Iwaszkiewicz J; Molecular Modeling Group, Swiss Institute of Bioinformatics, University of Lausanne, 1015 Lausanne, Switzerland;
  • Cérutti P; Centre National de la Recherche Scientifique UPS3044 "Baculovirus et Thérapie," F-30380 Saint-Christol-Lèz Alès, France;
  • Ozil A; Centre National de la Recherche Scientifique UPS3044 "Baculovirus et Thérapie," F-30380 Saint-Christol-Lèz Alès, France;
  • Loisel S; Animalerie, Faculté de Médecine, Université de Bretagne Occidentale-Université Européenne de Bretagne, 29238 Brest, France;
  • Pugnière M; INSERM, U1194, Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, Institut du Cancer de Montpellier, Institut Régional du Cancer, 34298 Montpellier, France;
  • Ubiali G; Centro di Terapia Cellulare "G. Lanzani," Divisione di Ematologia, Azienda Ospedaliera Papa Giovanni XXIII, 24122 Bergamo, Italy;
  • Zoete V; Molecular Modeling Group, Swiss Institute of Bioinformatics, University of Lausanne, 1015 Lausanne, Switzerland;
  • Michielin O; Molecular Modeling Group, Swiss Institute of Bioinformatics, University of Lausanne, 1015 Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, CH-1011 Lausanne, Switzerland; Département d'oncologie, Université de Lausanne-Centre Hospitalier Universitaire Vaudois, CH-1011
  • Berthou C; Centre Hospitalier Universitaire Regional, 29200 Brest, France;
  • Kadouche J; MAT Biopharma, 91030 Evry, France; Immune Pharmaceuticals Inc., New York, NY 10016;
  • Mach JP; Department of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland; and Biomunex Pharmaceuticals, 75006 Paris, France Jean-Pierre.Mach@unil.ch jgolay@asst-pg23.it.
  • Duonor-Cérutti M; Centre National de la Recherche Scientifique UPS3044 "Baculovirus et Thérapie," F-30380 Saint-Christol-Lèz Alès, France;
J Immunol ; 196(7): 3199-211, 2016 Apr 01.
Article in En | MEDLINE | ID: mdl-26921308
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Antibodies, Bispecific Limits: Animals / Humans Language: En Journal: J Immunol Year: 2016 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Immunoglobulin G / Antibodies, Bispecific Limits: Animals / Humans Language: En Journal: J Immunol Year: 2016 Document type: Article